Difficulty: Medium
Average Score: 81%
Practice
An elderly patient brings a bag of medications to the clinic. The nurse finds a bottle labeled Ativan and one labeled lorazepam, both of which are to be taken BID. There are also bottles labeled hydrochlorothiazide, Inderal, and rofecoxib, each to be taken once daily. Which conclusion is accurate?
Correct answer
B
Rationale
The correct answer is B) Lorazepam and Ativan are the same drug, so the dose is excessive. This is because Ativan is the brand name for lorazepam, so having both medications listed separately means the patient is taking a double dose of the same drug, which is potentially harmful.
Option A is incorrect because there are no known significant interactions between rofecoxib and Ativan. Option C is incorrect as lorazepam does not interfere with the action of Inderal. Option D is not directly supported by the information provided in the question.
From an educational perspective, this question highlights the importance of medication reconciliation and understanding brand versus generic names. It emphasizes the need for healthcare providers to clarify and consolidate medication lists to prevent duplications and potential drug interactions, especially in elderly patients who may be more vulnerable to the adverse effects of polypharmacy.
Option A is incorrect because there are no known significant interactions between rofecoxib and Ativan. Option C is incorrect as lorazepam does not interfere with the action of Inderal. Option D is not directly supported by the information provided in the question.
From an educational perspective, this question highlights the importance of medication reconciliation and understanding brand versus generic names. It emphasizes the need for healthcare providers to clarify and consolidate medication lists to prevent duplications and potential drug interactions, especially in elderly patients who may be more vulnerable to the adverse effects of polypharmacy.